ID

18386

Descrizione

Study Type: Interventional Study Design: Endpoint Classification: Efficacy Study Intervention Model: Single Group Assignment Masking: Open Label Primary Purpose: Treatment Official Title: Therapy for Chronic Cold Agglutinin Disease: A Prospective, Non-Randomized Multi-Center Study Demonstrating the Efficacy of Terminal Complement Inhibition in Patients With Cold Agglutinin Disease Using Eculizumab EudraCT-Nummer 2009-01696697 ClinicalTrials.gov-Identifier NCT01303952 https://clinicaltrials.gov/ct2/show/NCT01303952 Genehmigung durch Frau Ose

collegamento

https://clinicaltrials.gov/ct2/show/NCT01303952

Keywords

versioni (2)

1. 02-11-16 02-11-16 -
2. 05-11-16 05-11-16 -

Caricato su

2 november 2016

DOI

Per favore, per richiedere un accesso.

Licenza